These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1053 related items for PubMed ID: 9179054

  • 1. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY.
    Cancer; 1997 Jun 01; 79(11):2087-94. PubMed ID: 9179054
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB, Wang JH, Yan ZP, Qian S, Liu R.
    Cardiovasc Intervent Radiol; 2009 Jan 01; 32(1):52-61. PubMed ID: 18931871
    [Abstract] [Full Text] [Related]

  • 3. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI, Sung KB.
    Aliment Pharmacol Ther; 2009 Jun 15; 29(12):1291-8. PubMed ID: 19392861
    [Abstract] [Full Text] [Related]

  • 4. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan.
    Gastroenterology; 2006 Aug 15; 131(2):461-9. PubMed ID: 16890600
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A, Farinati F.
    Am J Gastroenterol; 2008 Apr 15; 103(4):914-21. PubMed ID: 18177453
    [Abstract] [Full Text] [Related]

  • 6. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH.
    Taehan Kan Hakhoe Chi; 2002 Jun 15; 8(2):189-200. PubMed ID: 12499805
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 8. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 10; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 9. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2009 May 10; 24(5):806-14. PubMed ID: 19207681
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH, Chen LH.
    Ai Zheng; 2004 Jul 10; 23(7):825-8. PubMed ID: 15248921
    [Abstract] [Full Text] [Related]

  • 11. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.
    Cancer; 2000 Dec 15; 89(12):2606-12. PubMed ID: 11135222
    [Abstract] [Full Text] [Related]

  • 12. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    Ann Surg Oncol; 2010 Mar 15; 17(3):869-77. PubMed ID: 20033326
    [Abstract] [Full Text] [Related]

  • 13. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.
    Cancer; 2009 Nov 15; 115(22):5132-8. PubMed ID: 19672999
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M.
    Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215
    [Abstract] [Full Text] [Related]

  • 15. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct 01; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim SH, Chung YH, Yang SH, Kim JA, Jang MK, Kim SE, Lee D, Lee SH, Lee D, Kim KM, Lim YS, Lee HC, Lee YS, Suh DJ.
    Korean J Hepatol; 2009 Sep 01; 15(3):320-30. PubMed ID: 19783881
    [Abstract] [Full Text] [Related]

  • 17. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.
    Am J Gastroenterol; 2003 May 01; 98(5):1181-5. PubMed ID: 12809846
    [Abstract] [Full Text] [Related]

  • 18. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 01; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi H, Yamamoto Y, Ichikawa S, Hasebe A, Yano M, Miyamoto Y, Ninomiya T, Ootani H, Takamura K, Kawasaki H, Otomi Y, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, Hirooka M, Hiasa Y, Matsuura B, Michitaka K, Onji M.
    Hepatogastroenterology; 2009 Jun 01; 56(89):213-7. PubMed ID: 19453060
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S.
    Int J Oncol; 2002 Aug 01; 21(2):427-32. PubMed ID: 12118341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.